• Founded in 2001
  • Employees: 321
  • Financial data: €792.77M Market Cap (on 13/02/2017)


Description :

Ablynx is engaged in the discovery and development of a novel class of therapeutic proteins, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonary disease.

Headquarters :

Technologiepark 21 Zwijnaarde (Ghent), 9052 Belgium

Send this to a friend